
|Articles|May 5, 2005
Tamoxifen shown to reduce gynecomastia in PCa patients
Tamoxifen (Nolvadex) reduces the frequency of gynecomastia and breast pain in prostate cancer patients taking bicalutamide (Casodex), according to a study in Lancet Oncology (2005; 6:295-300).
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Practical uses of AI across the urologic care continuum
2
Study progresses of nogapendekin alfa inbakicept for BCG-naïve NMIBC
3
The UroOnc Minute: Diet and Prostate Cancer, with Stephen J. Freedland, MD
4
Walter Hsiang, MD, discusses insurance-related barriers to kidney stone care
5



















